Enzymatic-Exchangeable MHC-I Single Chain Trimer for T Cell Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing MHC-I single chain trimers face challenges such as UV incompatibility with fluorescent labels, production of reactive nitroso species, photodamage, and laborious refolding conditions, limiting the generation of antigen-specific peptide-MHC complexes for detecting CD8+ T cells.
Innovation Solution
The use of a Baculovirus expression vector system to overexpress secreted MHC-I single chain trimer (SCT) proteins with an enterokinase-cleavable linker and a GS-linker for streptavidin tetramerization, allowing for high-yield secretion and peptide reloading, enabling efficient detection of antigen-specific T cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If UV-cleavable class I MHC is used for peptide exchange, then high-throughput generation of peptide MHC complexes is enabled, but UV incompatibility with fluorescent labels, production of reactive nitroso species and photodamage of MHC-I protein occurs
Solution Approach 1:
The patent replaces the UV-cleavable chemical system with an enzyme-cleavable system. Instead of using UV light to trigger peptide release, the invention employs enterokinase or other proteases to cleave a peptide linker, thereby substituting a mechanical/chemical activation method with a biological enzymatic process that avoids photodamage and fluorescent label incompatibility while maintaining high-throughput capability
Solution Approach 2:
The invention changes the activation parameter from UV light exposure to enzymatic cleavage conditions. By modifying the triggering mechanism from photolytic to proteolytic, the system achieves peptide exchange without the harmful effects of UV radiation, enabling compatibility with fluorescent labels and eliminating photodamage while preserving efficient peptide-MHC complex generation
2Quantity of substance
If MHC-I heavy chain and β2m are expressed in E. coli as inclusion bodies, then production is achieved, but laborious screening of different refolding conditions is required
Solution Approach 1:
The patent replaces the bacterial inclusion body refolding system with a eukaryotic secretory pathway system. Instead of expressing MHC-I in E. coli and performing laborious refolding, the invention uses baculovirus-infected insect cells or mammalian cells to naturally secrete properly folded MHC-I protein, substituting a complex post-translational refolding process with a streamlined secretory expression system
Solution Approach 2:
The invention enables the expression system to self-fold and secrete the MHC-I protein correctly through the eukaryotic secretory pathway. The cellular machinery automatically performs the folding and quality control functions that would otherwise require manual optimization of refolding conditions, eliminating the need for laborious screening while maintaining high production levels
3Stability of the object's composition
If closed peptide binding groove in MHC-I protein is used, then structural integrity is maintained, but optimal peptide size is limited requiring a 10-15 amino acid first linker
Solution Approach 1:
The patent segments the peptide binding groove into an open configuration during protein synthesis and secretion, allowing flexible peptide accommodation. The cleavable linker is positioned at the N-terminus of the binding groove, separating the structural MHC-I domain from the peptide loading domain, enabling the groove to transition from an open synthesis-friendly state to a closed peptide-bound state after enzymatic cleavage
Solution Approach 2:
The invention introduces dynamic flexibility to the peptide binding groove through the cleavable linker design. The groove transitions from an open, accessible state during secretion to a closed, stable state after peptide loading, with the enzymatically cleavable linker providing the mechanical transition point that allows the groove to adapt its conformation based on the loading stage
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the rapid production and specific detection of antigen-specific T cells with high sensitivity, comparable to traditional UV-exchange methods, and facilitates multiplexed tetramer staining, overcoming previous limitations.
Implementation Method 1
a first linker polypeptide comprising an enzyme-cleavable portion
Implementation Method 2
a mature MHC-I heavy chain polypeptide... bearing a BirA motif for streptavidin tetramerization
Data Source
AI summary
The present invention relates to methods to produce an enzymatic-exchangeable peptide Major Histocompatibility Complex Class I (MHC-I) Single Chain Trimer (SCT), or tetramer thereof, constructs encoding same and uses thereof, such as detection or isolation of antigen-specific CD8+ T cells. Said SCT comprises, in order from N-terminus to C-terminus, (i) a peptide ligand, (ii) a first linker polypeptide comprising an enzyme-cleavable portion, (i11) a β-2 microglobulin (β2ιτι) polypeptide, (iv) a second linker polypeptide, and (v) a mature MHC-I heavy chain polypeptide. In addition, a method of defining a peptide ligand suitable for successful production of a single fusion protein for peptide exchange is claimed.